We are only able to display limited information for this firm. We display more complete information for all of the following firms:

Cooley LLP excels at overseeing complex transactions in the life sciences market, advising both public and private clients on M&As, IPOs and follow-on offerings and collaborations in the sector. The firm is also sought after by early stage companies and VC investors looking for financing and investment opportunities. Reston-based practice co-head Christian Plaza advises on biotech, medtech and diagnostics companies on public and private offerings, VC investments and strategic collaborations, and M&A and capital markets specialist Marc Recht, based in Boston, joined the leadership team following Kay Chandler‘s retirement at the end of 2023. Palo Alto’s Ivor Elrifi chairs the firm’s global patent prosecution group, supporting clients looking to both create and enforce patents across, among others, the therapeutics, genetics and medical devices sectors, while Div Gupta is an experienced IPO lawyer based out of New York, who also handles VC transactions and M&A. With a practice split between Seattle and Palo Alto, Kate Hillier assists clients with their licensing strategies, research collaborations and clinical trial processes.

Legal 500 Editorial commentary

Key clients

  • Acrivon Therapeutics
  • Arvinas
Abbreviated data is displayed for this firm.

Work highlights

  • Advised Horizon Therapeutics on its agreement to be acquired by Amgen for $27.8bn.
  • Advised MapLight Therapeutics on its oversubscribed $225mn Series C financing.
Abbreviated data is displayed for this firm.